Used primarily in pharmaceutical research as an intermediate in the synthesis of bioactive compounds, particularly those targeting central nervous system disorders. Its structure supports the development of molecules with enhanced solubility and receptor binding properties. Commonly employed in the creation of experimental drug candidates for psychiatric and neurological conditions due to the presence of the ethylpiperazine and sulfonamide functional groups, which are known to influence blood-brain barrier penetration and pharmacokinetic profiles. Also utilized in structure-activity relationship (SAR) studies to optimize potency and selectivity in new therapeutic agents.